HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CIR Proposes Prioritizing Triclosan For Review In 2018

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel’s draft ingredient priority list for 2018 review consists of 14 ingredients, including triclosan. At their April meeting, panelists cited the potential for consumer confusion following recent FDA action banning the ingredient’s OTC use in antibacterial soaps, as well as endocrine-disruption concerns voiced by NGOs.

You may also be interested in...

CIR Expert Panel Finalizes 2018 Review Priorities At June Meeting

Fourteen cosmetic ingredients are up for first looks by the CIR panel in 2018. Also at its June meeting, the group issued two final ingredient reports and five tentative reports, as well as two insufficient data announcements, and tabled its parabens re-review in order to solicit outside expertise on new DART data.

CIR Slated To Examine New Paraben Data At Next Meeting

The Cosmetic Ingredient Review Expert Panel will take another look at paraben safety during its June meeting, considering new studies and adding ingredients to its assessment on the preservative group. NGO Women’s Voices for the Earth suggests that the panel may still be missing several relevant studies.

ACI Has $10M Plan For Supporting Antibac Ingredients, If FDA Hasn’t Already Closed The Door

The American Cleaning Institute is working to provide FDA with requested data to support three antibacterial agents that remain potentially viable for OTC use in consumer hand soaps following a September final rule that determined triclosan and 18 other such ingredients non-GRASE. However, FDA’s recent messaging around the issue – including that antibacterial soaps “may do more harm than good” – isn’t helping, it says.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts